Article PubMed
Arthritis Res Ther  (2016)

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis=> 54-week results from the PLANETRA study

Dae Hyun Yoo, Artur Racewicz; Jan Brzezicki, Roman Yatsyshyn; Edgardo Tobias Arteaga, Asta Baranauskaite; Carlos Abud-Mendoza, Sandra Navarra; Vladimir Kadinov, Irmgadt Goecke Sariego; Seung Suh Hong, Sung Young Lee